Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer

BJU International

Volumn 106, Issue 5, 2010, Pages 710-715

  Gradilone, Angela ^a   Petracca, Arianna ^a   Nicolazzo, Chiara ^a   Gianni, Walter ^d   Cortesi, Enrico ^b   Naso, Giuseppe ^b   Vincenzi, Bruno ^c   Cristini, Cristiano ^a   De Berardinis, Ettore ^a   Di Silverio, Franco ^a   Aglianò, Anna Maria ^a   Gazzaniga, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Divisione di Oncologia Medica   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d INRCA   (Italy)

Author keywords

circulating tumour cells; disease free survival; non muscle invasive bladder cancer; Survivin

Indexed keywords

CD45 ANTIGEN; COMPLEMENTARY DNA; CYTOKERATIN 8; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; MONOCLONAL ANTIBODY; POLYADENYLIC ACID; SURVIVIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER SURVIVAL; CELL ISOLATION; CIRCULATING TUMOR CELL; DISEASE FREE SURVIVAL; DNA SYNTHESIS; FOLLOW UP; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR CELL DESTRUCTION; TUMOR VOLUME;

EID: 77955887652     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09130.x     Document Type: Article

References (23)

1. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008 54 : 303 14
2. Kitamura H, Tsukamoto T. Early bladder cancer: concept, diagnosis, and management. Int J Clin Oncol 2007 11 : 28 37
3. Shariat SF, Karam JA, Lerner SP. Molecular markers in bladder cancer. Curr Opin Urol 2008 18 : 1 8
4. Margulis V, Lotan Y, Shariat SF. Survivin: a promising biomarker for detection and prognosis of bladder cancer. World J Urol 2008 26 : 59 65
5. Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy. Expert Opin Ther Targets 2008 12 : 463 76
6. Karam JA, Lotan Y, Karakiewicz PI et al. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol 2007 8 : 128 36
7. Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Survivin: a promising tumor biomarker. Cancer Lett 2007 249 : 49 60
8. Gonzalez S, Aubert S, Kerdraon O et al. Prognostic value of combined p53 and Survivin in pT1G3 urothelial carcinoma of the bladder. Am J Clin Pathol 2008 129 : 232 7
9. Chen YB, Tu JJ, Kao J, Zhou XK, Chen YT. Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma. Arch Pathol Lab Med 2008 132 : 224 31
10. Yie SM, Lou B, Ye SR et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008 15 : 3073 82
11. Yie SM, Luo B, Ye NY, Xie K, Ye SR. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Clin Exp Metastasis 2006 23 : 279 89
12. Pierga JY, Bidard FC, Mathiot C et al. Circulating tumour cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 2008 14 : 7004 10
13. Gazzaniga P, Gradilone A, Giuliani L et al. Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 2003 14 : 85 90
14. Hardingham JE, Kotasek D, Farmer B et al. Immunobead PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res 1993 53 : 3455 8
15. Sakaguchi M, Virmani AK, Ashfaq R et al. Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions. Br J Cancer 1999 79 : 416 22
16. Soloway MS, Lee CT, Steinberg GD, Ghandi AA, Jewett MA. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder. Urol Oncol 2007 25 : 338 40
17. Meng S, Tripathy D, Shete S et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci USA 2004 101 : 9393 8
18. Fehm T, Becker S, Duerr-Stoerzer S et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status. Breast Cancer Res 2007 9 : R74
19. Kallergi G, Agelaki S, Kalykaki A, Stournaras C, Mavroudis D, Georgoulias V. Phosphorylated EGFR and PI3KAkt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Breast Cancer Res 2008 10 : R80
20. Ignatiadis M, Georgoulias V, Mavroudis D. Micrometastatic disease in breast cancer: clinical implications. Eur J Cancer 2008 44 : 2726 36
21. Naoe M, Ogawa Y, Morita J et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 2007 109 : 1439 4
22. Raynor MP, Stephenson SA, Pittman KB, Walssh DCA, Henderson MA, Dobrovic A. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR. J Hematol Oncol 2009 2 : 24
23. Nakagawa T, Martinez SR, Goto Y et al. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes Clin Cancer Res 2007 13 : 4105 10